Airway anesthesia alone does not explain attenuation of histamine-induced bronchospasm by local anesthetics: A comparison of lidocaine ropivacaine dyclonine

Anesthesiology

Volumn 94, Issue 3, 2001, Pages 423-428

  Groeben, H ^a   Grosswendt T ^a   Silvanus, M T ^a   Pavlakovic, G ^a   Peters, J ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DYCLONINE; HISTAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; PLACEBO; ROPIVACAINE;

ADULT; ARTICLE; ATTENUATION; BRONCHOSPASM; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG POTENTIATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOCAL ANESTHESIA; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035095174     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200103000-00010     Document Type: Article

References (28)

1. The contribution of neurogcnic reflexes to hypertonic saline-induced bronchoconstriction in asthma
2. Effect of lidocaine on the ventilatory and airway responses to exercise in asthmatics
3. Effects of inhaled lidocaine on airway function in asthmatic subjects
4. Both intravenous and inhaled lidocaine attenuate reflex bronchochonstriction but at different plasma concentrations
5. Intravenous lidocaine and bupivacaine dose-dependently attenuate bronchial hyperce-activity in awake volunteers
6. Dyclonine-A new local anesthetic agent: Clinical evaluation
7. Awake endotracheal intubation: A review of 267 Cases
8. Fluorecence polarization immunoassay for the determination of therapeutic drug levels in human plasma
9. Tachyphylaxis to inhaled histamine in asthmatic subjects
10. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma
11. Daily spirometric variability: Normal subjects and subjects with chronic bronchitis with and without airflow obstruction
12. Within subject variability and percent change for significance of spirometry in normal subjects and in patients with cystic fibrosis
13. Reproducibility of spirometric measurements in normal subjects
14. Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents
15. The response to lidocaine in bronchial asthma
16. Lidocaine-induced bronchoconstriction in asthmatic patients
17. Concentrations of lidocaine in the blood after intravenous, intramuscular, epidural, and endotracheal administration
18. Lidocaine in arterial blood after laryngotracheal administration
19. Plasma lidocaine concentrations following endotracheal spraying with an aerosol
20. Acute toxicity, of ropivacaine compared with that of bupivacaine
21. Topical upper airway anesthesia with lidocaine increases airway resistance by impairing glottic function
22. Diagnosis of upper airway obstruction by pulmonary function testing
23. Rigid external resistances cause effort dependent maximal expiratory, and inspiratory flows
24. Prevention of lidocaine aerosol-induced bronchoconstriction with intravenous lidocaine
25. Stimulation of lung irritant receptors by cigarette smoke, carbon dust, and histamine aerosol
26. Central and local cholinergic components of histamine-induced bronchoconstriction in dogs
27. 2+ and tension in airway smooth muscle
28. Inhibitory effects of bupivacaine and lidocaine on adrenergic neuroeffector junctions in rat tail artery